Connect with us

Technology

Innocan Pharma Submits Investigational New Animal Drug Application to FDA’s Veterinary Center

Published

on

HERZLIYA, Israel and CALGARY, AB, July 26, 2024 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA’s Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver and assigned an Investigational New Animal Drug (INAD) number for its LPT-CBD (Liposome Platform Technology-Cannabidiol) product. This represents a significant step for the Company, as an INAD designation facilitates correspondence and data exchange with CVM to support LPT-CBD development as a new veterinary drug.

 

 

The Company further announced that following the assessment of LPT-CBD’s scientific package, the CVM recognized Innocan’s contribution to pursuing innovative animal drug products and technology and granted the company a sponsor fee waiver for fiscal year 2024.  

Innocan’s LPT-CBD is a proprietary drug delivery platform designed to provide prolonged-release CBD for chronic pain and well-being management in animals. Over the past year, repeated administration of LPT-CBD in dogs and other animals has demonstrated both efficacy and tolerability, providing sufficient evidence for the INAD application.

“We are thrilled by CVM’s response,” said Prof. Chezy Barenholz, CSO of Innocan Pharma. “The granted INAD will allow us to advance the investigational studies of LPT-CBD and share knowledge to support future discussions with CVM on LPT-CBD’s development plan. Moreover, the fee waiver, granted by CVM, supports our development and pursuit of innovative animal drug products and technology, further validating our approach and potential impact in veterinary medicine.”

Dr. Eyal Kalo, R&D Director at Innocan, added, “LPT-CBD is a unique technology that has proven itself worthy of the INAD fee waiver granted by CVM. This will streamline our efforts to deliver a unique solution for chronic pain management to the animal market.”

About Innocan Pharma:
Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients’ quality of life. This segment involves two drug delivery technologies: (i) LPT CBD-loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/

Contact Information:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377
info@innocanpharma.com 

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution Regarding Forward-Looking Information

Certain information set forth in this news release, including, without limitation, the Company’s plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. . The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedarplus.ca.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Logo: https://mma.prnewswire.com/media/2046271/3968398/Innocan_Pharma_Corporation_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/innocan-pharma-submits-investigational-new-animal-drug-application-to-fdas-veterinary-center-302207528.html

SOURCE Innocan Pharma Corporation

Continue Reading

Technology

CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026

Published

on

By

Dream ST will be on display as CoolFly highlights flagship Urban, high-performance Dream Pro and its expanding global dealer network

BERLIN, Sept. 6, 2026 /PRNewswire/ — CoolFly, a developer of personal electric aircraft and eVTOL technologies, is showcasing its Dream ST personal aircraft at IFA Berlin 2026, taking place September 4–8 at Messe Berlin.

Dream ST is on display at CityCube Hall B, Booth CCBB-143, in IFA’s Mobility area. While Dream ST is the aircraft physically presented at the show, CoolFly is also introducing its broader product portfolio, including high-performance Dream Pro and flagship Urban.

Dream ST is a lightweight, single-seat electric aircraft designed for personal and recreational flight, featuring a seated configuration and quick-fold design for easier transportation and storage.

Dream Pro extends the platform with greater payload, endurance and performance. It supports a maximum payload of 120 kg, reaches a maximum speed of 100 km/h, and can achieve up to 40 minutes of flight time with a 70 kg pilot onboard, depending on operating and environmental conditions.

Urban, CoolFly’s flagship personal aircraft, features a standing-position configuration and enclosed-propeller architecture, reflecting the company’s effort to create a more intuitive and distinctive personal flight experience.

All three aircraft share CoolFly’s self-developed NA80 flight control system. NA80 uses a dual-redundant architecture with two independent flight-control units, each integrating three aviation-grade inertial measurement units (IMUs). The system continuously monitors aircraft attitude and motion, supports millisecond-level fault detection and failover, and serves as a common technology foundation across CoolFly’s product portfolio.

Dream ST, Dream Pro and Urban have all obtained CE and FCC certifications for applicable product compliance requirements, supporting CoolFly’s continued international expansion.

CoolFly is also actively recruiting dealers, distributors and commercial partners worldwide, with a current focus on Europe, North America, Australia, the Middle East and other key markets.

Prospective partners and media are invited to visit CoolFly at IFA Berlin 2026, CityCube Hall B, Booth CCBB-143.

About CoolFly
CoolFly develops personal electric aircraft and eVTOL technologies, integrating aircraft design, propulsion and self-developed flight-control systems to make personal flight more accessible.

Media: press@coolflyaircraft.com
Business: support@coolflyaircraft.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/coolfly-to-showcase-personal-flight-portfolio-and-na80-flight-control-technology-at-ifa-berlin-2026-302870767.html

Continue Reading

Technology

Experience AI Companion in Everyday Life at Hisense IFA 2026

Published

on

By

BERLIN, Sept. 6, 2026 /PRNewswire/ — Hisense, a leading brand in global consumer electronics and home appliances, is inviting visitors at IFA 2026 to experience how AI can make everyday home routines simpler and more intuitive. Under the theme “Innovating a Brighter Life,” the Hisense AI Companion Suite, powered by ConnectLife, brings connected intelligence to the kitchen, laundry and living spaces.

Step into the kitchen and a simple question— “What should I make?”—can set the experience in motion. The AI Companion Refrigerator recognizes stored ingredients and suggests meal ideas based on personal preferences. Once a recipe is selected, it can sync with the AI Companion Oven to support automatic cooking, while the AI Companion Wine Cabinet recommends pairings and maintains suitable storage conditions. After the meal, the AI Companion Dishwasher recognizes dish conditions and adjusts cleaning, demonstrating how AI can support the journey from planning dinner to cleaning up.

In the laundry area, visitors can see how the AI Companion Laundry Suite turns a routine load into a simpler, more automated experience. By recognizing clothing characteristics, it selects suitable wash and dry cycles and adjusts the process automatically, creating a load-and-go experience.

The experience continues in the living space. The AI Companion Air Conditioner senses indoor conditions and user presence, adapting airflow as people move through the room. Meanwhile, the AI Companion Energy System considers weather and time-of-use electricity pricing to help optimize household energy use.

Building on ConnectLife’s support, Hisense is collaborating with Alexa+ to be among the first home appliance brands bringing smart home devices to Amazon’s Alexa+ AI assistant using Amazon’s new Smart Home AI Toolkit. Available in the coming months, Alexa+ customers will be able to control select Hisense air conditioners by simply saying what they need. Alexa+ will then map the request, navigate the settings, and complete the action for them.

Hisense’s approach to innovation has also earned recognition at IFA, with several of its products receiving awards. The Multi Function II Series, an all-in-one energy-saving HVAC solution, received a Winner Award, while the X-zone Master was named an Honoree. The U8 Air Master Air Conditioner, W60 3D Kitchen-fit Series and 60cm Integrated Wine Cabinet were also recognized that underscores Hisense’s focus on combining intelligent technology, thoughtful design and everyday usability.

Across these IFA scenarios, Hisense brings its Smart Home Companion capabilities to life through V AIOS, giving devices the ability to Sense what is happening, Think through what to do, Communicate naturally with users and across devices, and Execute tasks by orchestrating devices and services autonomously. Together, these capabilities help AI Companion Suites understand context, make decisions and take action, helping the home do more while asking less of its users.

About Hisense

Hisense, founded in 1969, is a globally recognized leader in home appliances and consumer electronics with operations in over 180 countries, specializing in delivering high-quality multimedia products, home appliances, and intelligent IT solutions. According to Omdia, Hisense ranks No. 1 globally in the 100-inch and over TV segment (2023-2026H1). As The Origin of RGB MiniLED, Hisense continues to lead the next-generation RGB MiniLED innovation. As the official sponsor of the FIFA World Cup 2026TM, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/experience-ai-companion-in-everyday-life-at-hisense-ifa-2026-302870765.html

Continue Reading

Technology

Roborock Reports 27.6% Revenue Growth in H1 2026, Reinforcing Global Market Leadership

Published

on

By

BERLIN, Sept. 6, 2026 /PRNewswire/ — Roborock, a global leader in home robotics engineered to simplify daily life, reported revenue of RMB 10.084 billion in the first half of 2026, up 27.6% year on year, while net profit attributable to shareholders rose 45.6% to RMB 986 million. The company also reached a new global milestone, with Roborock recognized as the world’s No.1 robotic vacuum cleaner brand by both IDC and Euromonitor International.

Global Expansion Continues to Strengthen Growth

Roborock’s international business continued to deliver strong growth in H1 2026 across both mature and high-potential markets. During Amazon Prime Day 2026, Roborock ranked No.1 in the robotic vacuum category in Germany, the United Kingdom, Spain, the Netherlands, Belgium, the United States and Canada. In Europe, Roborock reached a 45% share of the robotic vacuum market, with unit sales up 24% year on year, while wet-dry vacuum unit sales grew 112%. In North America, Roborock reached a 33% share of the robotic vacuum market, with unit sales increasing 30% year on year.

Momentum was also strong across key Asia-Pacific markets. Roborock ranked No.1 in both unit shipments and sales value in Australia, Korea, Taiwan region and Türkiye from Q1 2023 to Q1 2026. In Korea, the brand maintained more than 70% share of the premium robotic vacuum segment, while the S10 MaxV Ultra generated approximately KRW 28 billion in sales within ten days of its February 2026 launch. In Japan, Roborock continued to deepen its premium retail presence through cooperation with Yamada Denki, including dedicated brand displays and nationwide availability of flagship products. Across Asia-Pacific, the company continued to combine its global technology platform with localized channel, marketing and service strategies.

Roborock’s global leadership has also been independently recognized by IDC and Euromonitor International. According to IDC, Roborock ranked No.1 globally by both unit shipments and sales value among robotic vacuum brands in H1 2026, while Euromonitor International ranked the brand No.1 globally by retail sales value in 2025. Together, the two rankings reinforce Roborock’s global market leadership and reflect sustained consumer demand worldwide.

Sustained R&D Investment Supports Long-Term Competitiveness

Roborock continued to invest heavily in technology in the first half of 2026, with R&D spending reaching RMB 720 million, up 5.11% year on year and accounting for 7.14% of revenue. The company continues to build capabilities in intelligent navigation, AI-powered environmental perception, cleaning systems and robotic mobility, while increasingly bringing these technologies together at the system level rather than improving individual specifications in isolation. This integrated approach allows technologies proven in flagship products to be brought into a wider range of models and price segments, helping Roborock strengthen its portfolio while making advanced features available to more consumers.

IFA 2026 Highlights the Next Phase of Innovation

At IFA 2026, Roborock is showcasing its latest advances across indoor and outdoor cleaning. Its new robot vacuums and wet-dry vacuums bring advances in steam-powered care, adaptive cleaning and whole-home versatility, while the Roborock Saros Rover introduces a two-wheel-leg architecture designed to expand robotic mobility beyond flat floors. Roborock is also broadening its intelligent cleaning ecosystem with the debut of the RockAqua P1, its first intelligent pool cleaner, alongside the RockNeo Q2 LiDAR robotic mower, extending its autonomous cleaning capabilities across floors, pools and gardens.

View original content:https://www.prnewswire.co.uk/news-releases/roborock-reports-27-6-revenue-growth-in-h1-2026–reinforcing-global-market-leadership-302868216.html

Continue Reading

Trending